These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 26310188)
1. New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins. Ragni MV Drugs; 2015 Sep; 75(14):1587-600. PubMed ID: 26310188 [TBL] [Abstract][Full Text] [Related]
2. The evolution of recombinant factor replacement for hemophilia. Sankar AD; Weyand AC; Pipe SW Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983 [TBL] [Abstract][Full Text] [Related]
3. [Congenital hemophilia: a new treatment paradigm]. Shima M Rinsho Ketsueki; 2019; 60(6):647-658. PubMed ID: 31281158 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia. Schaub RG Biochem Pharmacol; 2011 Jul; 82(2):91-8. PubMed ID: 21453683 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive care for hemophilia and other inherited bleeding disorders. Page D Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262 [TBL] [Abstract][Full Text] [Related]
6. Real-life experience in switching to new extended half-life products at European haemophilia centres. Peyvandi F; Garagiola I; Boscarino M; Ryan A; Hermans C; Makris M Haemophilia; 2019 Nov; 25(6):946-952. PubMed ID: 31418967 [TBL] [Abstract][Full Text] [Related]
8. Changing paradigm of prophylaxis with longer acting factor concentrates. Carcao M Haemophilia; 2014 May; 20 Suppl 4():99-105. PubMed ID: 24762284 [TBL] [Abstract][Full Text] [Related]
9. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia. Mahdi AJ; Obaji SG; Collins PW Br J Haematol; 2015 Jun; 169(6):768-76. PubMed ID: 25754016 [TBL] [Abstract][Full Text] [Related]
10. The promise and challenges of bioengineered recombinant clotting factors. Pipe SW J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035 [TBL] [Abstract][Full Text] [Related]
11. The safety of pharmacologic options for the treatment of persons with hemophilia. Franchini M; Mannucci PM Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products. Berntorp E; Andersson NG Semin Thromb Hemost; 2016 Jul; 42(5):518-25. PubMed ID: 27096762 [TBL] [Abstract][Full Text] [Related]
13. Progress in the treatment of bleeding disorders. Bergman GE Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836 [TBL] [Abstract][Full Text] [Related]
14. [Substitution treatment in hemophilia. Critical measures and complications]. Schimpf K Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496 [No Abstract] [Full Text] [Related]
15. Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias. Mancuso ME; Mannucci PM Drug Des Devel Ther; 2014; 8():365-71. PubMed ID: 24729686 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of chromogenic assays for potency assignment and recovery of plasma-derived FVIII and FIX concentrates or their recombinant long acting therapeutic equivalents with potential application in treated pediatric hemophiliac patients. Amiral J; Seghatchian J Transfus Apher Sci; 2018 Jun; 57(3):363-369. PubMed ID: 29895509 [TBL] [Abstract][Full Text] [Related]
17. Management of joint bleeding in hemophilia. Simpson ML; Valentino LA Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238 [TBL] [Abstract][Full Text] [Related]
18. Safety of recombinant coagulation factors in treating hemophilia. Morfini M; Rapisarda CAP Expert Opin Drug Saf; 2019 Feb; 18(2):75-85. PubMed ID: 30681006 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis in real life scenarios. Fischer K; Konkle B; Broderick C; Kessler CM Haemophilia; 2014 May; 20 Suppl 4():106-13. PubMed ID: 24762285 [TBL] [Abstract][Full Text] [Related]
20. New products for the treatment of haemophilia. Laffan M Br J Haematol; 2016 Jan; 172(1):23-31. PubMed ID: 26456702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]